Adhaesiotm : a LINE OF PROGRAMS DESIGNED TO HELP PATIENTS STAY ON TRACK

Following your treatment as prescribed is essential, especially in the case of chronic diseases. This allows for better control of the disease, prevents complications, and improves quality of life.

The AdhaesioTM program line is designed to promote adherence to medication treatments through a comprehensive care approach focused on the patient’s condition. 

Each AdhaesioTM program will promote medication adherence by supporting patient care through their pharmacist, regardless of the brand of medication prescribed.   

AdhaesioTM programS cOULD OFFER PATIENTS :  

  • Optimal care by the pharmacist, which promotes medication adherence
  • A single point of contact that facilitates therapy monitoring 
  • An improved experience at every stage of the care pathway 
  • More time to focus on their health  

To learn more about AdhaesioTM and its various medication adherence programs, contact our team at info@accessa.ca.   

OstEoaccEs: aN AdhaesioTM   program

A THERAPEUTIC ADHERENCE PROGRAM FOR PATIENTS WITH OSTEOPOROSIS

People with osteoporosis treated with denosumab face several challenges, particularly regarding treatment adherence.   

It can be risky to forget or delay taking medication for this type of treatment, which is administered every six months. A simple delay of one to two weeks can exponentially increase the risk of fracture.   

That’s why Accessa created Osteoacces, a program that aims to improve treatment adherence among patients living with osteoporosis.

WHAT OstEoaccEs OFFERS :  

  • Better treatment adherence facilitating support and guidance from the pharmacist.
  • A single point of contact for treatment monitoring and renewal by the pharmacist, facilitating the care pathway. 
  • Local access and care directly at the pharmacy. 

By bringing together several manufacturers within the same program, Accessa facilitates consistent care focused on patient well-being. We aim to improve the patient experience at every stage of their care journey.

Osteoacces is open to all manufacturers marketing a biosimilar product for the treatment of osteoporosis who wish to enter into an agreement with Accessa to promote patient adherence to treatment. 

To enroll a patient in the OsteoAccess medication adherence program, go to the Accessa enrollment portal. 

Questions about our technology or services? Our team is always available by email or phone.